{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:01:26Z","timestamp":1769050886716,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,6,13]],"date-time":"2008-06-13T00:00:00Z","timestamp":1213315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s10875-008-9211-6","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T20:19:34Z","timestamp":1213301974000},"page":"501-511","source":"Crossref","is-referenced-by-count":35,"title":["IgA Anti-b2GPI Antibodies in Patients with Autoimmune Liver Diseases"],"prefix":"10.1007","volume":"28","author":[{"given":"Stella","family":"Gabeta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Gatselis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Liaskos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis A.","family":"Papamichalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Garagounis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Zachou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini I.","family":"Rigopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George N.","family":"Dalekos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,13]]},"reference":[{"key":"9211_CR1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Locksin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295\u2013306.","journal-title":"J Thromb Haemost"},{"key":"9211_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.clim.2004.02.012","volume":"112","author":"H Bas de Laat","year":"2004","unstructured":"Bas de Laat H, Derksen RH, de Groot PG. \u03b22-Glycoprotein I, the playmaker of the antiphospholipid syndrome. Clin Immunol 2004;112:161\u20138.","journal-title":"Clin Immunol"},{"key":"9211_CR3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/08916930500124312","volume":"38","author":"T Atsumi","year":"2005","unstructured":"Atsumi T, Amengual O, Yasuda S, Matsuura E, Koike T. Research around beta2-glycoprotein I: a major target for antiphospholipid antibodies. Autoimmunity 2005;38:377\u201381.","journal-title":"Autoimmunity"},{"key":"9211_CR4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/gut.34.5.658","volume":"34","author":"GN Dalekos","year":"1993","unstructured":"Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moutsopoulos HM. Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut 1993;34:658\u201364.","journal-title":"Gut"},{"key":"9211_CR5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11926-001-0031-4","volume":"3","author":"GN Dalekos","year":"2001","unstructured":"Dalekos GN, Zachou K, Liaskos C. The antiphospholipid syndrome and infection. Curr Rheumatol Rep 2001;3:277\u201385.","journal-title":"Curr Rheumatol Rep"},{"key":"9211_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/jaut.1999.0324","volume":"13","author":"C Petrovas","year":"1999","unstructured":"Petrovas C, Vlachogiannopoulos PG, Kordossis T, Moutsopoulos HM. Anti-phospholipid antibodies in HIV infection and SLE with or without antiphospholipid syndrome: comparisons of phospholipids specificity, avidity and reactivity with beta2-GPI. J Autoimmun 1999;13:347\u201355.","journal-title":"J Autoimmun"},{"key":"9211_CR7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2362.1993.tb00765.x","volume":"23","author":"GN Dalekos","year":"1993","unstructured":"Dalekos GN, Manoussakis MN, Zervou E, Tsianos EV, Moutsopoulos HM. Immunologic and viral markers in the circulation of anti-HIV negative heroin addicts. Eur J Clin Invest 1993;23:219\u201325.","journal-title":"Eur J Clin Invest"},{"key":"9211_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2362.2003.01110.x","volume":"33","author":"K Zachou","year":"2003","unstructured":"Zachou K, Liaskos C, Christodoulou DK, Kardasi M, Papadamou G, Gatselis N, et al. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur J Clin Invest 2003;33:161\u20138.","journal-title":"Eur J Clin Invest"},{"key":"9211_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00042737-200012010-00013","volume":"12","author":"GN Dalekos","year":"2000","unstructured":"Dalekos GN, Kistis KG, Boumba DS, Voulgari P, Zervou EK, Drosos AA, et al. Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol 2000;12:67\u201374.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9211_CR10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1172\/JCI0212337","volume":"109","author":"M Blank","year":"2000","unstructured":"Blank M, Krause I, Fridkin M, Keller N, Kopolovic J, Goldberg I, et al. Bacterial induction of autoantibodies to \u03b22-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2000;109:797\u2013804.","journal-title":"J Clin Invest"},{"key":"9211_CR11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaut.2005.01.016","volume":"24","author":"C Liaskos","year":"2005","unstructured":"Liaskos C, Rigopoulou E, Zachou K, Georgiadou S, Gatselis N, Papamihali R, et al. Prevalence and clinical significance of anticardiolipin antibodies in patients with type 1 autoimmune hepatitis. J Autoimmun 2005;24:251\u201360.","journal-title":"J Autoimmun"},{"key":"9211_CR12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clim.2006.01.002","volume":"119","author":"K Zachou","year":"2006","unstructured":"Zachou K, Liaskos C, Rigopoulou E, Gabeta S, Papamichalis P, Gatselis N, et al. Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases. Clin Immunol 2006;119:203\u201312.","journal-title":"Clin Immunol"},{"key":"9211_CR13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1023\/A:1023274505128","volume":"18","author":"PG Vlachoyiannopoulos","year":"1998","unstructured":"Vlachoyiannopoulos PG, Petrovas C, Tektonidou M, Krilis SA, Moutsopoulos HM. Antibodies to \u03b22glycoprotein I: urea resistance, binding specificity and association with thrombosis. J Clin Immunol 1998;18:308\u201391.","journal-title":"J Clin Immunol"},{"key":"9211_CR14","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/ard.2003.017939","volume":"63","author":"S Cucnik","year":"2004","unstructured":"Cucnik S, Kveder T, Krizaj I, Rozman B, Bozic B. High avidity anti-\u03b22-glycoprotein I antibodies in patients with antiphospholipid syndrome. Ann Rheum Dis 2004;63:1478\u201382.","journal-title":"Ann Rheum Dis"},{"key":"9211_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10067-005-1156-z","volume":"25","author":"M Samarkos","year":"2006","unstructured":"Samarkos M, Davies KA, Gordon C, Loizou S. Clinical significance of IgA anticardiolipin and anti-beta2-GPI antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Clin Rheumatol 2006;25:199\u2013204.","journal-title":"Clin Rheumatol"},{"key":"9211_CR16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaut.2006.09.007","volume":"27","author":"GM Iverson","year":"2006","unstructured":"Iverson GM, von Muhlen CA, Staub HL, Lassen AJ, Binder W, Norman GL. Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autantibodies that preferentially target domain 4 of beta2-GPI. J Autoimmun 2006;27:266\u201371.","journal-title":"J Autoimmun"},{"key":"9211_CR17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2249.1999.01007.x","volume":"117","author":"G Lakos","year":"1999","unstructured":"Lakos G, Kiss E, Regeczy N, Tarjan P, Soltesz P, Zeher M, et al. Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype. Clin Exp Immunol 1999;117:574\u20139.","journal-title":"Clin Exp Immunol"},{"key":"9211_CR18","first-page":"55","volume":"318","author":"E Cucurull","year":"1999","unstructured":"Cucurull E, Gharavi AE, Diri E, Mendez E, Kapoor D, Espinosa LR. IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus. Am J Med Sci 1999;318:55\u201360.","journal-title":"Am J Med Sci"},{"key":"9211_CR19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.imbio.2006.01.004","volume":"211","author":"A Pahor","year":"2006","unstructured":"Pahor A, Hojs R, Holc I, Ambrozic A, Cucnik S, Kveder T, et al. Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis. Immunobiology 2006;211:689\u201394.","journal-title":"Immunobiology"},{"key":"9211_CR20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.autrev.2006.06.014","volume":"6","author":"HL Straub","year":"2006","unstructured":"Straub HL, Frank M, Ranzolin A, Norman GL, Iverson GM, vonMuhlen CA. IgA antibodies to beta2-glycoprotein I and atherosclerosis. Autoimmun Rev 2006;6:104\u20136.","journal-title":"Autoimmun Rev"},{"key":"9211_CR21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1067\/mob.2001.117659","volume":"185","author":"RM Lee","year":"2001","unstructured":"Lee RM, Branch DW, Silver RM. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Am J Obstet Gynecol 2001;185:748\u201353.","journal-title":"Am J Obstet Gynecol"},{"key":"9211_CR22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/ard.62.6.540","volume":"62","author":"S Carmo-Pereira","year":"2003","unstructured":"Carmo-Pereira S, Bertolaccini ML, Escudero-Contreras A, Khamashta MA, Hughes GR. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity. Ann Rheum Dis 2003;62:540\u20133.","journal-title":"Ann Rheum Dis"},{"key":"9211_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1740-2557-4-3","volume":"4","author":"PA Papamichalis","year":"2007","unstructured":"Papamichalis PA, Zachou K, Koukoulis GK, Veloni A, Karacosta EG, Kypri L, et al. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis\/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis 2007;4:3.","journal-title":"J Autoimmune Dis"},{"key":"9211_CR24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International autoimmune hepatitis group: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929\u201338.","journal-title":"J Hepatol"},{"key":"9211_CR25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","volume":"54","author":"EI Rigopoulou","year":"2005","unstructured":"Rigopoulou EI, Davies ET, Pares A, Zachou K, Liaskos C, Bogdanos DP, et al. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 2005;54:528\u201332.","journal-title":"Gut"},{"key":"9211_CR26","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1478-3231.2007.01586.x","volume":"27","author":"EI Rigopoulou","year":"2007","unstructured":"Rigopoulou EI, Davies ET, Bogdanos DP, Liaskos C, Mytilinaiou M, Koukoulis GK, et al. Anti-mitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary bilary cirrhosis. Liver Int 2007;27:1226\u201331.","journal-title":"Liver Int"},{"key":"9211_CR27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cca.2007.01.023","volume":"380","author":"EI Rigopoulou","year":"2007","unstructured":"Rigopoulou EI, Bogdanos DP, Liaskos C, Koutsoumpas A, Baum H, Vergani D, et al. Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clin Chim Acta 2007;380:118\u201321.","journal-title":"Clin Chim Acta"},{"key":"9211_CR28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1568-9972(03)00030-2","volume":"2","author":"S Cullen","year":"2003","unstructured":"Cullen S, Chapman R. Primary sclerosing cholangitis. Autoimmun Rev 2003;2:305\u201312.","journal-title":"Autoimmun Rev"},{"key":"9211_CR29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0168-8278(03)00387-8","volume":"39","author":"DS Kyriakou","year":"2003","unstructured":"Kyriakou DS, Alexandrakis MG, Zachou K, Passam F, Stathakis N, Dalekos GN. Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol 2003;39:679\u201385.","journal-title":"J Hepatol"},{"key":"9211_CR30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jhep.2004.11.023","volume":"42","author":"A Tsikrikoni","year":"2005","unstructured":"Tsikrikoni A, Kyriakou DS, Rigopoulou EI, Alexandrakis MG, Zachou K, Passam F, et al. Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. J Hepatol 2005;42:393\u20139.","journal-title":"J Hepatol"},{"key":"9211_CR31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaut.2005.08.002","volume":"25","author":"K Zachou","year":"2005","unstructured":"Zachou K, Rigopoulou EI, Tsikrikoni A, Alexandrakis MG, Passam F, Kyriakou DS, et al. Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production. J Autoimmun 2005;25:283\u20138.","journal-title":"J Autoimmun"},{"key":"9211_CR32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","volume":"32","author":"P Angulo","year":"2000","unstructured":"Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AE, et al. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 2000;32:182\u20137.","journal-title":"J Hepatol"},{"key":"9211_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cccn.2005.02.002","volume":"357","author":"SS Pierangeli","year":"2005","unstructured":"Pierangeli SS, Harris EN. Clinical laboratory testing for the antiphospholipid syndrome. Clin Chim Acta 2005;357:17\u201333.","journal-title":"Clin Chim Acta"},{"key":"9211_CR34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1740-2557-1-2","volume":"1","author":"K Zachou","year":"2004","unstructured":"Zachou K, Rigopoulou EI, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical diagnosis and to study pathogenesis of the disease. J Autoimmune Dis 2004;1:2.","journal-title":"J Autoimmune Dis"},{"key":"9211_CR35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0168-8278(99)80096-8","volume":"30","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ. Behaviour and significance of autoantibodies in type 1 autoimmune hepatitis. J Hepatol 1999;30:394\u2013401.","journal-title":"J Hepatol"},{"key":"9211_CR36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.21583","volume":"45","author":"S Oertelt","year":"2007","unstructured":"Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007;45:659\u201365.","journal-title":"Hepatology"},{"key":"9211_CR37","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","volume":"43","author":"J Wesierska-Gadek","year":"2006","unstructured":"Wesierska-Gadek J, Penner E, Battezzati PM, Selmi C, Zuin M, Hitchman E, et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 2006;43:1135\u201344.","journal-title":"Hepatology"},{"key":"9211_CR38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1196\/annals.1381.028","volume":"1107","author":"A Tanaka","year":"2007","unstructured":"Tanaka A, Nezu S, Uegaki S, Mikami M, Okuyama S, Kawamura N, et al. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis. Ann N Y Acad Sci 2007;1107:259\u201370.","journal-title":"Ann N Y Acad Sci"},{"key":"9211_CR39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/096120398678919624","volume":"7","author":"NM Shah","year":"1998","unstructured":"Shah NM, Khamashta MA, Atsumi T, Hughes GR. Outcome of patients with anticardiolipin antibodies: a 10\u00a0year follow-up of 52 patients. Lupus 1998;7:3\u20136.","journal-title":"Lupus"},{"key":"9211_CR40","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. New Engl J Med 2003;349:1526\u201333.","journal-title":"New Engl J Med"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-008-9211-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-008-9211-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-008-9211-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:10:04Z","timestamp":1559275804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-008-9211-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,13]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["9211"],"URL":"https:\/\/doi.org\/10.1007\/s10875-008-9211-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,13]]}}}